Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|April 1, 2020
Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?Luca Cantini, Raffit Hassan, Daniel H Sterman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 3, 2022
Immunotherapy for mesothelioma: Moving beyond single immune check point inhibitionLuca Cantini, Isaac Laniado, Vivek Murthy, et al.
European Radiology|February 9, 2026
What are RECIST 1.1 progressions made of? Variability in double-read oncology trialsHubert Beaumont, Luca Cantini, Kamal S Saini, et al.
JCO Global Oncology|July 8, 2020
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 PandemicZelmira Ballatore, Lucia Bastianelli, Filippo Merloni, et al.
Drugs in Context|August 17, 2022
Non-small-cell lung cancer: how to manage EGFR-mutated diseaseFederica Pecci, Luca Cantini, Giulio Metro, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Management of lung cancer patients during COVID-19 pandemic: dos, don'ts and don't knowsMariangela Torniai, Veronica Agostinelli, Luca Cantini, et al.
Cancer Management and Research|June 29, 2018
Optimal management of resected gastric cancerRiccardo Giampieri, Michela Del Prete, Luca Cantini, et al.
Molecular and Clinical Oncology|February 2, 2018
Long-responders to anti-HER2 therapies: A case report and review of the literatureLuca Cantini, Mirco Pistelli, Agnese Savini, et al.
Cancers|October 14, 2022
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic PerspectivesValeria Cognigni, Federica Pecci, Alessio Lupi, et al.
Current Treatment Options in Oncology|June 10, 2021
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal CancerFederica Pecci, Luca Cantini, Alessandro Bittoni, et al.
Pageof 7